FORCE advocates for families facing hereditary cancer in areas such as access to care, research funding, insurance and privacy.

Policy Archive Successful Effort

Establishment of National HBOC Week and Previvor Day

Hereditary Cancer Awareness

On September 15th, 2010, in a unanimous show of support, the U.S. House of Representatives voted in favor of a Resolution sponsored by Rep. Wasserman Schultz (FL-20) establish National Hereditary Breast and Ovarian Cancer Week and National Previvor Day. National HBOC week is now recognized as an annual event, beginning the last Sunday in September and ending the first Saturday in October. National Previvor Day occurs on the Wednesday of that week. 

The timing—the transition between National Ovarian Cancer Awareness Month (September) and National Breast Cancer Awareness Month (October)—demonstrates the link between these two cancers. It is estimated that up to 25% of ovarian cancers are due to hereditary factors and approximately 10% of breast cancers are hereditary. FORCE is proud to have spearheaded this initiative to bring attention to hereditary breast and ovarian cancer (HBOC) syndromes and to recognize their impact on the families affected.

Read the text of the resolution, H Res #1522. 

 

Update: With the growth of the hereditary cancer community and expansion of FORCE's mission to serve a broader population, National Hereditary Cancer Week was instituted in 2020.

Take Action Now 2021 Priorities Advocacy Archive Public Policy Initiatives

News Briefs

7/1/2021 - Effective today, North Carolina's Medicaid program will cover genetic counseling and BRCA mutation testing for those who have "higher than average risk" for the development of certain cancers based on specific personal and/or family history of the disease.

6/30/2021 - FORCE added its support to a letter sent to Senate HELP Committee leadership urging the prioritization of diagnostics reform on behalf of the In-vitro Diagnostics (IVD) Reform Coalition and the communities it represents.

5/21/2021 - Joined the Defense Health Research Consortium in a letter asking House and Senate leadership to continue support for the defense health research programs funded through the Department of Defense (DoD) Congressionally Directed Medical Research Programs (CDMRP). 

More